Frontiers | CRISPR/Cas9-Based therapeutics as a promising strategy for management of Alzheimer’s disease: progress and prospects
1 Laboratory of Nanotherapeutics and Regenerative Medicine, Department of Nanotechnology, University of Kashmir, Srinagar, India 2 Department of Higher Education, Government of Jammu and Kashmir, Srinagar, India 3 Chemical Biology Unit, Institute of Nano Science and Technology, Knowledge City, Mohali, Punjab, India 4 Department of Animal Biotechnology, Faculty of Biotechnology, College of Applied Life Sciences and Interdisciplinary Graduate Program in Advanced Convergence Technology and Science, Jeju
